Supriya Lifescience Limited (SUPRIYA) — Capital Reinvestment Ratio
Supriya Lifescience Limited (SUPRIYA) has a Capital Reinvestment Ratio of 0.76x as of September 2025, meaning it reinvests 1% of its operating cash flow (Rs555.65 Million) in capital expenditures (Rs422.49 Million). Check how tangible is Supriya Lifescience Limited's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Supriya Lifescience Limited Capital Reinvestment Ratio (2018–2025)
This chart tracks Supriya Lifescience Limited's Capital Reinvestment Ratio across 8 annual periods. For the full cash flow conversion analysis, see SUPRIYA operating cash flow.
Annual Capital Reinvestment Ratio for Supriya Lifescience Limited (2018–2025)
Year-by-year Capital Reinvestment Ratio for Supriya Lifescience Limited from 2018 to 2025. See Supriya Lifescience Limited free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.94x | Rs1.73 Billion | Rs1.62 Billion | ▼ -26.8% |
| 2024 | 1.29x | Rs1.13 Billion | Rs1.46 Billion | ▼ -21.5% |
| 2023 | 1.64x | Rs661.87 Million | Rs1.08 Billion | ▲ +33.4% |
| 2022 | 1.23x | Rs488.01 Million | Rs599.04 Million | ▲ +103.4% |
| 2021 | 0.60x | Rs799.30 Million | Rs482.41 Million | ▲ +185.6% |
| 2020 | 0.21x | Rs1.16 Billion | Rs245.25 Million | ▲ +48.1% |
| 2019 | 0.14x | Rs486.72 Million | Rs69.45 Million | ▼ -49.5% |
| 2018 | 0.28x | Rs174.52 Million | Rs49.30 Million | — |